Friday, December 14, 2018

Professional Societies Disclose Their Disclosure Policies, But Why Won’t Some Discuss Them?

Last month I wrote about “How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?” The article dealt with the fallout of Baselga’s failure to disclose millions of dollars he had received from industry, and his subsequent resignation as Memorial Sloan Kettering Cancer Center’s physician-in-chief as well as from a number of corporate boards. The disclosure issue had initially...

Battling Obesity and Cancer – An Integrated Team’s Approach

When the American Society of Clinical Oncology (ASCO®) conducted the National Cancer Opinion Survey in July 2017, the results revealed something rather surprising. The survey showed that while 78 percent and 66 percent of respondents correctly identified tobacco use and sun exposure, respectively, as risk factors for cancer, only 31 percent correctly identified obesity as a risk factor for...

Otis Brawley Discusses Life After Leaving the American Cancer Society

When Otis W. Brawley, MD — who had served as the face of the American Cancer Society (ACS) for the past 11 years—resigned earlier this month as the organization’s senior vice president and chief medical and scientific officer to pursue new opportunities at an as-yet-to-be disclosed major university, many members of the cancer community were surprised and shocked. Brawley had...

National Cancer Institute Awards $16 million Grant to Establish a Cancer Health Equity Center

The National Cancer Institute (NCI) has awarded a five-year, U.S. $ 16 million grant to establish a cancer health equity center at the University of Florida and partner institutions, inducing, Florida A&M University and the University of Southern California. Combined, Florida and California have the highest cancer incidence and mortality in the United States and the new center is designed...

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose millions of dollars in payments from industry, I reached out to learn a little bit more about current institutional conflict of interest policies, especially in light of the current trend promoting academic-governmental-industry collaborations in research. Although...

How a Hollywood-and-Scientist Dream Team Created a New Paradigm in Collaborative Cancer Research

This year marks the 10th anniversary of the launch of Stand Up To Cancer (SU2C)—an enterprise that was at its inception an innovative and somewhat radical concept in cancer research: creating collaborative dream teams of researchers from various disciplines and multiple institutions to put forth the best science that could be translated into treatments for patients within a deadline...

Opioid Prescribing and Cancer Pain – Contemporary Challenges

Each year, about 1.7 million Americans are diagnosed with cancer, and about 600,000 die from cancer. Fortunately, there are now over 16 million cancer survivors in the U.S. We know that pain is an issue for cancer patients, especially with advancing disease bringing about the end of life. We also know that cancer survivors may be plagued by chronic...

‘Stronger by Sharing’ Founder Wins Pinnacle Book Achievement Award for 2018 Memoir

Earlier this year, thirteen years after losing her mother to glioblastoma, Manon Rinsma-Leonard, MSc*, found the inner strength to share her personal, heartbreaking, experience with the world. "13 Diamonds – Life Before Death from a Child’s Perspective", the book she wrote, is an exuberant, deeply personal, emotional, uncensored and painfully honest, memoir about family, loss, hope, sadness, joy, resilience...

Stronger by Sharing: 5 Reasons Why It’s Important to Share Your Story

Bursts of laughter, tears of joy, sobs of sadness, love, grief, anger, it is all part of our story we call ‘Life’. It is a journey, a quest to pursue happiness. There are ups and downs, highs and lows, for some more extreme than others, but either way there are so many stories out there. Stories that are worth telling! With...

Why Do We Need a Right-to-Try Bill in America?

Congress recently passed, and President Trump signed, the “Right to Try” bill that gives dying patients limited access to drugs that have not yet been approved by the U.S. Food and Drug Administration (FDA). Our Founders would be astonished that we need such a bill. Nowhere does the U.S. Constitution give the federal government the authority to regulate the practice...

Related articles